NYSE:OGEN | Free Cash Flow | ORAGENICS INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.2M
2025-12-31-$2.84M
2025-03-31-$2.11M
2024-12-31-$2.02M
2024-03-31-$3.06M
2023-12-31-$1.1M
2023-03-31-$2.11M
2022-12-31-$2.43M$3,438.00-$2.44M
2022-03-31-$5.64M$87,047.00-$5.72M
2021-12-31-$2.48M$19,753.00-$2.5M
2021-03-31-$4.33M
2020-12-31-$3.63M
2020-03-31-$3.82M
2019-12-31-$3.94M$13,860.00-$3.95M
2019-03-31-$2.21M
2018-12-31-$2.98M$64,485.00-$3.04M
2018-03-31-$1.37M
2017-12-31-$1.36M
2017-03-31-$1.9M
2016-12-31-$1.96M$0.00-$1.96M
2016-03-31-$1.62M
2015-12-31-$1.66M$0.00-$1.66M
2015-03-31-$1.29M$72,237.00-$1.36M
2014-12-31-$1.18M$90,544.00-$1.27M
2014-03-31-$1.58M$18,889.00-$1.6M
2013-12-31-$1.22M$1,160.00-$1.22M
2013-03-31-$1.58M
2012-12-31-$1.74M
2012-03-31-$1.14M
2011-12-31-$1.39M
2011-03-31-$1.12M
2010-12-31-$1.77M-$91,297.00-$1.86M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$9.25M
2024-12-31-$8.6M
2023-12-31-$7.29M
2022-12-31-$15.23M$127,519.00-$15.36M
2021-12-31-$13.47M$43,876.00-$13.51M
2020-12-31-$16.95M
2019-12-31-$13.01M$25,214.00-$13.04M
2018-12-31-$9.08M$124,727.00-$9.2M
2017-12-31-$6.36M
2016-12-31-$7.08M$27,179.00-$7.1M
2015-12-31-$5.19M$102,511.00-$5.29M
2014-12-31-$5.56M$110,673.00-$5.67M
2013-12-31-$6.76M$18,809.00-$6.78M
2012-12-31-$5.21M$11,095.00-$5.22M
2011-12-31-$5.49M
2010-12-31-$6.45M$88,084.00-$6.54M